Cormorant Asset Management’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Cormorant Asset Management’s Portfolio BITI Stock Details BITI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-50,000	Closed	-$1.32M	–	96
2016 Q1	$1.32M	Hold	50,000	–	–	0.2%	66
2015 Q4	$718K	Hold	50,000	–	–	0.09%	73
2015 Q3	$655K	Hold	50,000	–	–	0.1%	80
2015 Q2	$999K	Buy	+50,000	New	+$1.04M	0.13%	72

Cormorant Asset Management's BITI Position: Q2 2016 in Review

Cormorant Asset Management sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q2 2016, closing a stake of 50,000 shares — an estimated $1.32M sold.

Cormorant Asset Management first reported a position in BITI in Q2 2015 and held it in 4 quarters. The position peaked at $1.32M in Q1 2016. 0 funds tracked by Wall St. Rank hold BITI as of Q2 2016.

Cormorant Asset Management reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q2 2016 after selling out during the quarter.
Cormorant Asset Management sold 50,000 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q2 2016, an estimated $1.32M.
Cormorant Asset Management first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2015 and held it in 4 quarters.
Cormorant Asset Management's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $1.32M in Q1 2016.
0 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q2 2016.

Based on Cormorant Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.